A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin.
about
Structural characterization of viral epitopes recognized by broadly cross-reactive antibodiesInfluenza virus hemagglutinin stalk-based antibodies and vaccinesBroadly neutralizing antibodies against influenza virus and prospects for universal therapiesMechanisms of hemagglutinin targeted influenza virus neutralizationHighly Conserved Protective Epitopes on Influenza B VirusesHeterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidityInfluenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 VirusesAntibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding SiteConserved Neutralizing Epitope at Globular Head of Hemagglutinin in H3N2 Influenza VirusesReverse vaccinology 2.0: Human immunology instructs vaccine antigen designModified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseasesInfluenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protectionImmune history shapes specificity of pandemic H1N1 influenza antibody responses.Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo.Emerging antigenic variants at the antigenic site Sb in pandemic A(H1N1)2009 influenza virus in Japan detected by a human monoclonal antibody.Humanized antibody neutralizing 2009 pandemic H1N1 virus.Epitope mapping of the hemagglutinin molecule of A/(H1N1)pdm09 influenza virus by using monoclonal antibody escape mutants.Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice.Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.H7N9 influenza virus neutralizing antibodies that possess few somatic mutationsInfluenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses.Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza virusesAntibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice.Broader neutralizing antibodies against H5N1 viruses using prime-boost immunization of hyperglycosylated hemagglutinin DNA and virus-like particles.N-linked glycosylation in the hemagglutinin of influenza A viruses.Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies.Advances in the development of universal influenza vaccines.Cross-protective immune responses elicited by live attenuated influenza vaccinesAntibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaquesIdentification of dominant antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin antigen of pandemic H1N1 influenza virus.Re-engaging cross-reactive memory B cells: the influenza puzzle.Broad protection against influenza infection by vectored immunoprophylaxis in mice.A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular headFc functional antibodies in humans with severe H7N9 and seasonal influenzaOptions and obstacles for designing a universal influenza vaccineImplications of broadly neutralizing antibodies in the development of a universal influenza vaccine.Characterization of influenza vaccine immunogenicity using influenza antigen microarrays.Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses.Influenza virus antigenicity and broadly neutralizing epitopes.
P2860
Q26823492-192A9C1A-6F2A-42A2-A846-CC9F63807E19Q27001190-D1533935-B452-4CB8-B6A7-B8EE5912DCDEQ27010503-9094989B-D85D-4E99-AE22-BC7CFC01DE98Q27302234-4450E2B6-31B4-46D8-B08C-81D8912094D7Q27671404-5AFC90EE-4C09-44D1-B61B-BD564351C1FBQ27673861-22217F91-FC7D-4B25-BBE2-9A1A0C5303DFQ27675477-A0B7F48C-C42D-474D-89BD-661D22E0D5A2Q27679927-1FC0FD9A-E27A-40F7-87B1-27D029A3FEDFQ27683198-EAD0F6D8-C4F5-4C9A-BFFD-A07597DA5209Q28075274-BCB3C4A6-2DE3-4072-8176-029065582567Q30209342-5C8433E9-E39B-4CA2-8221-B84A1DDF75D5Q30209769-0DEEAABD-6946-4C66-A948-DF2CDE373E06Q30352126-E295F1AC-18AB-42DC-A391-58F01A0FB634Q30353823-9A36D87B-BBD7-4084-B77F-D4308997C31AQ30354791-5F862816-5AFA-4873-9605-AD51147A4DA8Q30364911-1591C4AC-452C-4471-8D03-57F8CD3F93F7Q30365694-EFE60BC1-C504-450D-8EEE-98EE296C0690Q30370985-936AF2F0-C4C7-4C1B-94E4-46264BC286F2Q30384878-72CE9348-859E-4CD0-8F32-91648402235FQ30385356-1B00A8CA-56E6-4448-9EB0-3E8E7C98D3C8Q30413677-3FD9111A-9FB3-469D-A748-CEB8371D7C94Q30414515-D3A24229-10EF-40A4-ABAF-1682414BB66FQ30414712-2AC66ED7-2DC1-4868-915B-604433E58A37Q30417383-2C0B03D8-F3E7-4B22-AFDE-69B947D8309BQ30418340-1AD4ED19-62C0-4349-846C-16AF2B79E0DDQ30420126-CC409BA7-DC72-49B4-983A-2847038D5358Q30420990-BF59621F-E301-4CFE-A1C5-1793795AD29FQ30421502-D3F9827C-FCF8-4A2D-B4B2-E6F7E6BFC089Q30426540-1F9DFAAE-6844-4605-8D40-BF09037471F2Q30427950-58CA1F5C-22F5-4FE5-97C4-A7E5EE7DD630Q30428189-EC5FFFBC-C70C-41F9-9B20-D29E5AD137E9Q33353517-89463508-366A-48F7-90D4-4EE80DC08A54Q33649040-71EE1BD5-7CE1-4386-A2B2-029B2758634AQ33743865-3927CA2D-7165-48A7-82E9-CC6A423CCEF7Q33877811-53DBAA0A-DCC5-44AE-BF45-67BC21643A80Q34102290-D795A4A3-3700-4045-B573-33A18C5109D9Q34520430-CF09E797-1BDF-48E0-A53F-C3CEF536986BQ34755553-0ECA63EC-677B-43DA-9A87-82CFF184EEADQ35132253-56969EAE-7FB8-48A2-88FC-92EBB341D4C0Q35685270-F236A110-83A6-4F76-A1DE-DC83F6FB28EF
P2860
A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
A broadly neutralizing human m ...... enza H1N1 virus hemagglutinin.
@ast
A broadly neutralizing human m ...... enza H1N1 virus hemagglutinin.
@en
type
label
A broadly neutralizing human m ...... enza H1N1 virus hemagglutinin.
@ast
A broadly neutralizing human m ...... enza H1N1 virus hemagglutinin.
@en
prefLabel
A broadly neutralizing human m ...... enza H1N1 virus hemagglutinin.
@ast
A broadly neutralizing human m ...... enza H1N1 virus hemagglutinin.
@en
P2093
P2860
P50
P356
P1433
P1476
A broadly neutralizing human m ...... enza H1N1 virus hemagglutinin.
@en
P2093
Chelsey J Huffman
Jens C Krause
Tshidi Tsibane
P2860
P304
10905-10908
P356
10.1128/JVI.00700-11
P577
2011-08-17T00:00:00Z